EUCTR2008-006526-34-DK进行中（未招募）1 期
Intravesikal instillation af Botulinum toxin type A til patienter med urge urininkontinens
Gynækologisk-obstetrisk afd. G, Glostrup Hospital0 个研究点目标入组 20 人开始时间: 2008年11月26日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •- Myndig habil kvinde = 18 år der forstår dansk
- •- Mindst 6 måneders anamnese med UUI som dominerende symptom i.h.t. ICS-definition
- •- Forsøgt mindst 2 forskellige antimuskarinika
- •- Heldøgns vandladningsfrekvens (TV) = 10/døgn ved 4-dages væske-vandladningsskema (VVS)
- •- Inkontinensepisodefrekvens (IEF) = 1/døgn ved 4-dages VVS
- •- Døgndiurese < 40 ml/kg
- •- Residualurin < 100 ml
- •- POP-Q = stadium 2
- •- Spontan uroflowmetri > 15 ml/sek ved ladt volumen > 150 ml, eller normal invasiv tryk-flow under-søgelse
- •- Cystometrisk overaktiv detrusor inkontinens ved volumen < 300 ml
- •- Naturlig eller kirurgisk menopause, kirurgisk sterilitet eller sikker antikonception (p-piller, spiral, de-potinjektion af gestagen, subdermal implantation, hormonal vaginalring samt transdermal depot-plaster)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Blæreneoplasier
- •- Symptomer eller tegn på neurologisk eller neuromuskulære lidelser, herunder myastenia gravis
- •- Behandling med aminoglykosider
- •- Graviditet eller amning
- •- Ønsker eller evner ikke oplæring i ren intermitterende selvkateterisation (RIK)
研究者
相似试验
已完成
2 期
Botulinum toxin A intravesical injections in the treatment of Bladder Pain Syndrome/ Interstitial Cystitis.NL-OMON31587Vrije Universiteit Medisch Centrum12
进行中（未招募）
不适用
Botulinum toxin A intravesical injections in the treatment of Bladder Pain Syndrome/Interstitial CystitisInterstitial Cystitis (IC) is a syndrome characterized by bladder pain associated with urgency, frequency, nocturia, dysuria and sterile urine. The patho-physiology remains largely unclear. No universally, effective, treatment exists. Botulinum toxin-A (BTX-A) inhibits the release of acetylcholine at the presynaptic cholinergic junction resulting in temporally muscle relaxation and bladder desensitisation. We explore the effects of intravesical injections with BTX-A in the treatment of IC.EUCTR2007-005164-27-NLresearch office urology VUmc12
已完成
2 期
Intravesical injection of botulinum toxin A in patients with refractory interstitial cystitis/ painful bladder syndromeInterstitial cystitis/ Painful bladder syndrome (IC/ PBS)JPRN-UMIN000004554Department of Urology, Unversity of Tokyo hospital50
进行中（未招募）
不适用
Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) - CP(BTX)PSEUCTR2007-001602-24-DEDepartment of Urology and Pediatric Urology - Justus-Liebig-University Giessen
进行中（未招募）
不适用
Intra-articular injection of botulinum toxin for treatment of shoulder pain after stroke.hemiplegic shoulder painMedDRA version: 14.1Level: SOCClassification code 10028395Term: Musculoskeletal and connective tissue disordersSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-004682-32-ITFONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO